Schonfeld Strategic Advisors’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-102,379
| Closed | -$578K | – | 1904 |
|
2023
Q4 | $578K | Buy |
+102,379
| New | +$578K | ﹤0.01% | 1156 |
|
2022
Q4 | – | Sell |
-23,861
| Closed | -$210K | – | 2538 |
|
2022
Q3 | $210K | Buy |
+23,861
| New | +$210K | ﹤0.01% | 2256 |
|
2022
Q2 | – | Sell |
-89,662
| Closed | -$2.18M | – | 2488 |
|
2022
Q1 | $2.18M | Buy |
89,662
+44,550
| +99% | +$1.08M | 0.02% | 654 |
|
2021
Q4 | $1.45M | Sell |
45,112
-17,141
| -28% | -$552K | 0.01% | 734 |
|
2021
Q3 | $2.78M | Buy |
+62,253
| New | +$2.78M | 0.03% | 552 |
|